New chemo mix could reduce side effects in lymphoma transplants
Disease control
Recruiting now
This study tests whether a new form of the drug carmustine (without ethanol) causes fewer side effects than the standard version in lymphoma patients receiving a stem cell transplant. About 49 adults with Hodgkin or non-Hodgkin lymphoma who are already candidates for transplant w…
Phase: PHASE2 • Sponsor: VIVUS LLC • Aim: Disease control
Last updated May 19, 2026 10:15 UTC